Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CP-101,606 in Acute Ischemic Stroke
NCT00073476Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Sep 2003
- Modality
- Small Molecules
- Countries
- 8
01
Overview
Phase 2, randomised, double-blind trial in ischemic stroke comparing Traxiprodil with Placebo (2 arms). Primary endpoints: No or minimal neurological deficit at last visit and Marked neurological improvement at last visit. Started Sep 2003; status: terminated.
02
Drugs
traxoprodil
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00073476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00073476.